Status:
UNKNOWN
Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development.
Lead Sponsor:
Assiut University
Conditions:
Phenylketonurias
Eligibility:
All Genders
1-3 years
Brief Summary
The study aim is to follow up body growth(body weight by kg, length by cm, head circumference, abdominal circumference, and body mass index ) and mental development of infants on phenylalanine restric...
Detailed Description
Phenylketonuria is rare genetic disease caused by mutation in gene of phenylalanine (Phe) hydroxylase that converts Phenylalanine into tyrosine. The absence of this enzyme leads to elevation and accum...
Eligibility Criteria
Inclusion
- Infants with hyperphenylalaninemia on special formula and diet
- Infants of both sexes
- Age since birth till three years
- Type of feeding : diet restriction of phenylalanine
- Controls: normal healthy children match with cases in the same social class, age and sex
Exclusion
- Age greater than three years
- Patients diagnosed with PKU and not regular in feeding for special diet and formula.
- PKU patients not diagnosed since birth
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04302194
Start Date
May 1 2020
End Date
October 1 2021
Last Update
March 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.